Pharma Matters

Expanding for What Comes Next

Vetter’s Carsten Press discusses the strategy behind the company’s global investments and what they mean for injectable drug customers.

Released By Vetter Pharma International

Expanding for What Comes Next


Vetter is expanding its capacity, capabilities, and global footprint to meet evolving demand across the injectable drug market. In this episode of Pharma Matters, Carsten Press, Managing Director at Vetter, discusses the market forces shaping the company’s investment strategy, the value these developments will bring to customers, and how Vetter is maintaining quality and reliability as it grows.

Request more information from Vetter Pharma International

Keep up with the story. Subscribe to the Contract Pharma free daily
newsletter